drugset / Trial / NCT03461718

Ketamine for Endoscopic Sedation in Outpatient Adult Endoscopy.

NCT03461718

Phase 2 Completed 66 enrolled Brooke Army Medical Center
RandomizedParallel-groupSingle-blindTreatment

Summary

We will be investigating the use of ketamine in sedation for endoscopic procedures, specifically outpatient endoscopy including esophagoduodenoscopy (EGD) and colonoscopy. Participants will be randomized to one of two arms including conventional moderate sedation with midazolam and fentanyl or the ketamine arm. They will then undergo the planned procedure. Physicians preforming the procedure will be surveyed following the procedure and patients will be surveyed twice, once after meeting criteria for discharge on day of the procedure and a second time 48 hours following the procedure.

Timeline

Start
2018-03-05
Primary completion
2019-10-01
Completion
2019-10-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketamine Small molecule 10 mg Intravenous
Subject Ketamine Small molecule 20 mg Intravenous
Comparator Fentanyl Other / unclassified 150 ug
Background Midazolam Small molecule 1 mg Intravenous
Background Midazolam Small molecule 5 mg Intravenous

Indications

No indication recorded.